In 2025, Hailun Xie and team analyzed 6,568 cancer patients from multiple hospitals. They made an inflammatory score from white blood cell count and C-reactive protein levels in blood, grouping it as mild, moderate, or severe. They tracked survival and nutrition changes using stats like survival curves and risk models.